Back to Authors

Holland, Steven M.

https://orcid.org/0000-0003-3207-5464

Mayo Clinic

National Institutes of Health

Citations 3

Immune Reconstitution Inflammatory Syndrome as a Posttransplantation Complication in Primary Immunodeficiency With Disseminated Mycobacterium avium
Manion, Maura , Dimitrova, Dimana , Pei, Luxin , Gea‐Banacloche, Juan , Lisco, Andrea , Zerbe, Christa S. , Freeman, Alexandra F. , Holland, Steven M. , Kanakry, Christopher G. , Kanakry, Jennifer A. , Zelazny, Adrian M. , Sereti, Irini

Clinical Infectious Diseases | June 11, 2019 | Volume: 70 | Issue: 4 | Pages: 676-679

10.1093/cid/ciz507 Get It

Abstract Patients with primary immunodeficiencies undergoing allogeneic hematopoietic cell transplantation (HCT) for difficult-to-control infections can experience immune reconstitution inflammatory syndrome (IRIS) following engraftment. In 3 patients with post-HCT IRIS related to mycobacterial infection, in vitro data demonstrate the emergence of pathogen-specific immune responses and a concomitant rise in plasma inflammatory markers.
Treatment of Posaconazole-Induced Peripheral Neuropathy With Methylprednisolone and Magnesium Infusions: A Case Report
Hussain, Sadia, Nissen, Susan E., Holland, Steven M. , Sandroni, Paola , Lionakis, Michail S. , Nissen, Susan, Nissen, Susan

Open Forum Infectious Diseases | February 23, 2019 | Volume: 6 | Issue: 2 | Pages: No page available

10.1093/ofid/ofz031 Get It

Abstract The tolerability of long-term posaconazole use remains poorly defined. We present a patient who developed peripheral neuropathy following long-term exposure to the tablet formulation of posaconazole, which was treated with methylprednisolone and magnesium infusions. The potential role of methylprednisolone and magnesium infusions in managing this potentially irreversible triazole-associated complication requires further study.
Spectrum of myeloid neoplasms and immune deficiency associated with germline GATA2 mutations
Mir, Muhammad A. , Kochuparambil, Samith T. , Abraham, Roshini S. , Rodriguez, Vilmarie , Howard, Matthew H., Jackson, Amie E., Holland, Steven M. , Patnaik, Mrinal M. , Hsu, Amy P.

Cancer Medicine | January 26, 2015 | Volume: 4 | Issue: 4 | Pages: 490-499

10.1002/cam4.384 Get It

AbstractGuanine‐adenine‐thymine‐adenine 2 (GATA2) mutated disorders include the recently described MonoMAC syndrome (Monocytopenia and Mycobacterium avium complex infections), DCML (dendritic cell, monocyte, and lymphocyte deficiency), familial MDS/AML (myelodysplastic syndrome/acute myeloid leukemia) (myeloid neoplasms), congenital neutropenia, congenital lymphedema (Emberger's syndrome), sensorineural deafness, viral warts, and a spectrum of aggressive infections seen across all age groups. While considerable efforts have been made to identify the mutations that characterize this disorder, pathogenesis remains a work in progress with less than 100 patients described in current literature. Varying clinical presentations offer diagnostic challenges. Allogeneic stem cell transplant remains the treatment of choice. Morbidity, mortality, and social costs due to the familial nature of the disease are considerable. We describe our experience with the disorder in three affected families and a comprehensive review of current literature.